Patent ductus arteriosus (PDA) and response to late surfactant treatment in premature infants.
Madeline S BeaucheneAlison M CunninghamAmy H StanfordAdrianne Rahde BischoffJohn M DagleDanielle R RiosJonathan M KleinRegan E GiesingerPatrick J McNamaraPublished in: Journal of perinatology : official journal of the California Perinatal Association (2023)
weeks gestation, with HRF, response to surfactant after postnatal day 6 is influenced by PDA status. Future trials should consider PDA status which may enhance diagnostic precision and refine patient selection for late surfactant treatment.